Yatharth Hospital & Trauma Care Services Limited (NSE:YATHARTH)

Market Cap	79.69B +54.9%
Revenue (ttm)	12.33B +39.2%
Net Income	1.75B +34.3%
EPS	18.20 +23.6%
Shares Out	96.35M
PE Ratio	45.44
Forward PE	32.75
Dividend	n/a
Ex-Dividend Date	n/a

Volume	274,984
Open	828.55
Previous Close	827.00
Day's Range	794.95 - 839.75
52-Week Range	538.25 - 889.90
Beta	0.96
Analysts	Strong Buy
Price Target	986.00 (+22.94%)
Earnings Date	Aug 11, 2026

About NSE:YATHARTH

Yatharth Hospital & Trauma Care Services Limited, together with its subsidiaries, owns and operates super-specialty hospitals in India. The company offers services in the areas of medicine, cardiology, neurosciences, general surgery, nephrology and urology, pediatrics, gastroenterology, pulmonology, gynecology, orthopedics, spine and rheumatology, plastic and cosmetic surgery, ear, nose, throat, endocrinology, critical care, dermatology, nuclear medicine, and cancer and bone marrow transplant. It also provides services in the areas of GI surger...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 2008
• Employees: 4,895
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: YATHARTH

Financial Performance

In fiscal year 2026, NSE:YATHARTH's revenue was 12.33 billion, an increase of 39.22% compared to the previous year's 8.86 billion. Earnings were 1.75 billion, an increase of 34.34%.

Analyst Summary

According to 4 analysts, the average rating for YATHARTH stock is "Strong Buy." The 12-month stock price target is ₹986.00, which is an increase of 22.94% from the latest price.

Price Target

₹986.00

(22.94% upside)

Analyst Consensus: Strong Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 8, 2026

Data Sources Report a data error